The target derivative is gentamicin linked with L-Val-L-Ala by an ester linkage. It was synthesized by esterification method, which included the reaction of hydroxyl group on (carbon No.5) of gentamicin with the acid chloride of the corresponding dipeptide. The preparation of new derivative of gentamicin involved protection of the primary and secondary amino groups of gentamicin, by ethylchloroformate (ECF) to give N-carbomethoxy gentamicin which was used for further chemical synthesis involving the free hydroxyl groups.
‫الخالص‬ ‫ة‬

Introduction
Gentamicin is an aminoglycoside antibiotic, used to treat many types of bacterial infections, particularly those caused by Gramnegative bacteria. Gentamicin sulphate is the sulphate salt, or a mixture of such salts, of the antibiotic substances produced by the growth of Micromonospora purpurea.. Gentamicin is a bactericidal antibiotic that works by binding the 30S subunit of the bacterial ribosome, interrupting protein synthesis (1, 2) . Like all aminoglycosides, when gentamicin is given orally it is not systemically active. This is because it is not absorbed to any appreciable extent from the small intestine. Aminoglycosides are poorly absorbed from the gastrointestinal tract and are administered parenterally (4) . Their high water solubility and low protein-binding facilitate distribution (5, 6) .
Gentamicin is the only heat-stable antibiotic, hence its use during orthopedic surgery when high temperatures are required for the setting of cements (e.g. hip replacements) (1,3) . Colon -specific delivery of bioactive compounds received extensive investigations, utilizing the significantly variable bio environments of the different parts of the G.I.T (4) . Prodrugs are bioreversible derivatives of drug molecules that undergo an enzymatic and/or chemical transformation in vivo to release the active parent drug. Strategies to improve the oral bioavailability and achieve specific targeting have been the most important developments in prodrug design during the last 5 years. (5) Transport of di-or tripeptides across plasma membranes in the small intestine and the kidney proximal tubules play a pivotal role in efficient absorption of protein digestion products. The absorption process is mediated actively by H + -coupled peptide transporters localized in the brush-border membranes of these epithelia.
(6)
There are two types of human peptide transporters: (7) Human Peptide Transporters 1 (hPepT1) that is present in the brush border of the small intestine and predominantly in the upper part, Human Peptide Transporters 2 (hPepT2), which are mostly abundant in the kidney (6) . The identification of two peptide transporters, PEPT1 and PEPT2, represented a major step forward toward molecular understanding of the physiological and pharmacological significance of peptide transporters (6) ,among various membrane transporters, peptide transporters are the most attractive targets in prodrug design to improve oral drug absorption (7) .
The peptide transporter is a possible route for improving the intestinal absorption of pharmacologically active amino acid analogues. As examples of compounds without a peptide bond, the aminopeptidase inhibitor arphamenine, the antiviral agent valacyclovir and 4-aminophenylacetic acid were reported to be substrates for peptide transporter (8) .
Figure1. Substrates of peptide transporters
Materials and Methods
All chemicals and solvents used during synthesis were of analytical grade and used without further purification as follow ; Gentamicin Sulphate(Hyperchem, China), L-Alanine, Acetone, Boc -L -Valine, Chloroform, Ethanol (98%),Methanol (98%) Thionyl chloride , and Trifluoroacetic acid (TFA) (Fluka AG, Germany), Acetyl Chloride, Acetic acid (glacial) , Dichloromethane, methylene chloride, Hydrochloric acid (33%) Pyridine ,and Tetrahydrofuran (THF)( BDH, England), Dimethylformamide (DMF)and Triethylamine (TEA)( Fluka AG , Switzerland), Ethyl chloroformate (ECF) and Silica gel F254 aluminum sheets,( Merck, Germany), Anisole(Gillard chem.,UK),
Completion of reactions and the purity of compounds were ascertained by thinlayer chromatography (TLC), using silica gel GF254 (type 60) precoated aluminum sheets, Merck (Germany) exposed to UV-254nm light, or by reacting with iodine vapor, or with Ninhydrine spray reagents for detection of dipeptide, and the eluent used is Chloroform: 
Chemical synthesis General method for synthesis of intermediate Ia
The primary and secondary amino groups of gentamicin were protected (9), (10) , by Ethylchloroformate (ECF) to give Ncarbomethoxy Gentamicin which was used for further chemical synthesis involving the free secondary hydroxyl groups.
Gentamicin Sulphate (0.0008 mol, 0.46 gm) dissolved in methylene chloride (60 ml) containing triethylamine (0.013mol, 1.8 ml) and was cooled to (-5 o C). ECF (0.0043 mol, 0.53 ml) in 40 ml of THF (tetrahydrofuran) was added. The reaction mixture was left at (-5 o C) for 30 min with continues stirring. The temperature of the reaction mixture was allowed to rise to room temperature gradually and the mixture was continuously and vigorously stirred for 6 hrs. The solvent was evaporated under vacuum. The residue was redissolved in methylene chloride and D.W. Acidified with 5% hydrochloric acid solution to wash out the un-reacted materials. The organic layer was separated, washed several times with saturated sodium chloride solution and then D.W. The organic layer was dried using anhydrous magnesium sulfate filtered and methylene chloride was evaporated under vacuum leaving a white precipitate recrystallized using (70% methanol).The percentage yield, and Rf values are listed in table 1, The IR characteristic bands of Ncarboethoxy-gentamicin (compound Ia) are listed in table 2, CHNO data are listed in table 3.
Chemical synthesis of compound Ib (Synthesis of Boc L-val -L-ala dipeptide)
Coupling is done by conventional solution method; (0.082 mol, 1.8 gm) of Boc -L-Valine in 10 ml of DMF were cooled to 0° C, (0.019 mol ,4.12 gm) of DCCI was added the solution was stirred with cooling (9) A solution of (0.082 mol, 0.73 gm) alanine in 10 ml of DMF (previously cooled to 0°C) was added to the first stirred solution then kept the reaction mixture cooled to (-15 °C) for 10 min, HOBt (0.015, 2.16gm) was added with stirring. The stirring was continued for two days at 0° C .Then two days at room temp .Filtration was carried out to remove DCU precipitate formed during the reaction, the solvent was evaporated under reduced pressure to remove DMF .The residue was redissolved in chloroform (50 ml), washed with cold water (2× 20 ml). The organic layer collected, dried over anhydrous magnesium Sulphate, the volume was reduced then, diethyl ether was added to get crystals kept in deep freeze. The physical appearance, percent yield, melting point, and Rf values are listed in table 1, The IR characteristic bands are listed in figure 3, CHNO data are listed in table 3 (9) .
Synthesis of Boc L-Val -L-ala acetyl chloride (compound Ic)
This intermediate was synthesized by the conversion of compound Ib into its corresponding acid chloride by reacting with thionylchloride and as follows:
Compound Ib (0.0057 mol, 1.64 gm) was dissolved in (30) ml chloroform . Excess of thionyl chloride (0.0085mol, 0.6 ml) was added drop wise with continuous stirring at 0•C. The temperature of the reaction was raised gradually and refluxed for three hours. The reaction mixture then cooled; the volume was reduced by evaporation to small volume to remove excess of thionyl chloride then the residue was re-dissolved in 30 ml of chloroform and re -evaporate to ensure the removal of all thionyl chloride. Brown, oily residue was obtained. This compound was used immediately for other synthesis. (11) 
Chemical synthesis of Boc L-val-L-ala ester of gentamicin (compound Id)
Compound Ia (0.00066 mol, 0.5gm) was dissolved in 50 ml of (1:1) Pyridine: DMF, cooled in ice bath to 0 o C with continuous stirring. Compound Ic (0.00066 mol, 0.19 gm) were dissolved in 30 ml of chloroform,(Prepared immediately and cooled) was added drop wise to the (previous solution) .
The reaction mixture was stirred under cooling for 5 hours, then left to stand for 12 hour at same temperature .The solvent was evaporated to small volume. 50 ml of water added to remove the pyridine HCl and the DMF (12) . Then evaporated under vacuum leaving a dark yellowish precipitate re-crystallized by dichloroethane
Chemical synthesis of compound 1; Synthesis of L-val L-ala ester of Gentamicin; (deprotecting of amine groups of Gentamicin)
Compound (Id) (0.00005 mol, 0.05gm) was dissolved in methylene chloride (10ml) and was stirred with TFA (10 ml) for 1 hr. at 0 o C in the presence of (1-2) drops of anisole, and kept at room temp for 3 hrs. TLC for the reaction mixture was performed to ensure the removal of the amino-protective group. Ether (30 ml) was added to the reaction mixture and the resulting precipitate was collected. The precipitate was suspended in D.W. (30 ml) and the pH was adjusted to 5 with 5% NaHCO3. The reaction mixture was filtered and a yellow precipitate was collected, washed with D.W. (30 ml × 2), dried in an oven at 50 o C. The precipitate was triturated with ether, filtered and crystallized using petroleum ether to form yellowish crystals (11, 13) .
The physical appearance, percent yield, melting point, and Rf values are listed in table 1, CHNO  data are listed in table 3, and The IR  characteristic 
Results and Discussion
Spectral data and chemistry
The synthesis of compounds (intermediates and end products) is presented in scheme 1.The synthesized compounds were identified and characterized by their melting points, Rf values, and physical appearance, these data are listed in the 
Conclusion
The synthesis of the designed compound as derivative of Gentamicin was successfully achieved by following the stated procedures as previously described and resulted in the preparation of the proposed compound in reasonable yields. The spectral and CHNO analysis have confirmed their chemical structures. IR spectra were recorded and found that the characteristic bands of the compounds indicate the presence of certain groups which comply with the proposed chemical structure.
